written on 27.06.2014

NICE proposes U-turn on Novartis's Glivec for GIST

TAGS: ,

Bayer/Onyx Pharmaceuticals Stivarga (regorafenib) is approved for the treatment of GIST in the US, but a European filing in this indication is currently under review.